References
- Knothe H, Shah P, Kromery V et al. Transferable resis-tance to cefotaxime, cefoxitin, cefamandole and cefuroxime in clinical isolates of Klebsiella pneumoniae and Serratiamarcescens. Infection 1983; 11: 315–317.
- Garbarg-Chenon A, Vu Thien H, Labia R et al. Characterization of a plasmid coding for resistance to broad-spectrum cephalosporins in Salmonella typhimurium. Drugs Exp Clin Res 1991; 15: 145–50.
- Villa L, Mammina C, MiriagouV et al. Multidrug and broad-spectrum cephalosporin resistance among Salmonella enterica serotype Enteritidis clinical isolates in southern Italy. J Clin Microbiol 2002; 40: 2662–5.
- Yates CM, Brown DJ, Edwards CF et al. Detection of TEM-52 in Salmonella enterica serovar Enteritidis isolated in Scotland. J Antimicrob Chemother 2004; 53: 407–8.
- Batchelor M, Hopkins K, Threlfall EJ et al. blaCTX-M genes in clinical Salmonella isolates recovered from humans in England and Wales from 1992 to 2003. Antimicrob Agents Chemother 2005; 49: 1319–1322.
- Poirel L., Gniadkowski M., Nordmann P. Biochemical analysis of the ceftazidime-hydrolysing extended-spectrum beta-lactamase CTX-M-15 and of its structurally related beta-lactamase CTX-M-3. J Antimicrob Chemother 2002; 50: 1031-4.
- Bradford P. Extended-spectrum beta-lactamases in the 21st century: characterization, epidemiology, and detection of this important resistance threat. Clin Microbiol Rev 2001; 14: 933–951.
- Tzouvelekis LS, Tzelepi E, Tassios PT, Legakis NJ. CTX-M-type beta-lactamases: an emerging group of extended-spectrum enzymes. Int J Antimicrob Agents 2000; 14: 137–142.
- Pagani L, Dell'Amico E, Migliavacca R et al. Multiple CTX-M-type extended- spectrum beta-lactamases in nosocomi-al isolates of Enterobacteriaceae from a hospital in Northen Italy. J Clin Microbiol 2003; 41: 4264-426 9.
- Livermore DM, Hawkey PM. CTX-M: changing the face of ESBLs in the UK. J Antimicrob Chemother 2005; 56: 451–454.
- Simarro E, Navarro F, Ruiz J, et al. Salmonella enteri-ca serovar Virchow with CTX-M-like beta-lactamase in Spain.J Clin Microbiol 2000; 38: 4676-4678.
- Weill FX, LaiIler R, Praud K, et al. Emergence of extended-spectrum-beta-lactamase (CTX-M-9)-producing mul-tiresistant strains of Salmonella enterica serotype Virchow in poultry and humans in France. J Clin Microbiol. 2004; 42: 5767–5773.
- Yates C, Amyes S. Extended-spectrum beta-lactamases in non-typhoidal Salmonella spp. isolated in the UK are now a reality: why the late arrival? J Antimicrob Chemother. 2005; 56: 262–264.
- NCCLS, 2003. Methods for dilution antimicrobial sus-ceptibility tests for bacteria that grow aerobically; approved standard M7-A6. National Committee for Clinical Laboratory Standards. Villanova, PA.
- NCCLS, 2003. Performance standards for antimicro-bial disk susceptibility tests M2-A7. National Committee for Clinical Laboratory Standards. Villanova, PA.
- NCCLS, 2005. Performance standards for antimicro-bial susceptibility testing; fifteenth informational supplement M100-515. National Committee for Clinical Laboratory Standards. Villanova, PA.
- Mabilat C, Goussard S. PCR detection and identifica-tion of extended-spectrum 13-lactamases. In: DH Persing, TF Smith, FC Tenover and TJ White (eds.), Diagnostic molecular microbiology: principles and applications. American Society for Microbiology, Washington, D.C. 1993: 553-563
- Rasheed JK, Jay C, Metchock B et al. Evolution of extended-spectrum beta-lactam resistance (SHV-8) in a strain of Escherichia coli during multiple episodes of bacteremia. Antimicrob Agents Chemother. 1997; 41: 647–653.
- Acikgoz ZC, Gulay Z, Bicmen M, Gocer S, Gamberzade S. CTX-M-3 extended-spectrum beta-lactamase in a Shigella sonnei clinical isolate: first report from Turkey. Scand J Infect Dis. 2003; 35: 503–505
- Lartigue MF, Poirel L, Heritier C, Tolun V, Nordmann P. First description of CTX-M-15-producing Klebsiella pneu-moniae in Turkey. J Antimicrob Chemother 2003; 52: 315–316